(Q39479445)

English

Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

0 references

author name string

Qiang Pan

1

1 reference

Europe PubMed Central

12 September 2017

Xue-jun Yang

2

1 reference

Europe PubMed Central

12 September 2017

Hua-min Wang

3

1 reference

Europe PubMed Central

12 September 2017

Xue-tao Dong

4

1 reference

Europe PubMed Central

12 September 2017

Wei Wang

5

1 reference

Europe PubMed Central

12 September 2017

Yu Li

6

1 reference

Europe PubMed Central

12 September 2017

Jing-min Li

7

1 reference

Europe PubMed Central

12 September 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

12 September 2017

Cell Biochemistry and Biophysics

1 reference

Europe PubMed Central

12 September 2017

62

1 reference

Europe PubMed Central

12 September 2017

1

1 reference

Europe PubMed Central

12 September 2017

185-191

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s12013-011-9280-7

0 references

Epidemiology and etiology of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Predictive and prognostic markers in human glioblastomas

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Immunotherapy of diffuse gliomas: biological background, current status and future developments

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Molecular genetic markers as predictors of response to chemotherapy in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Mismatch repair defects and O6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9280-7

21 January 2018

Identifiers

10.1007/S12013-011-9280-7

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39479445&oldid=1830118127"